Clinical trial
Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)
NCT06604091 is registered in ClinicalTrials.gov with The Second Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cohort Profile:The Shandong Adenomyosis Cohort of Population Undergoing Reproductive Technology (SAart)
- Lead sponsor
- The Second Hospital of Shandong University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 30, 2024
- Completion date
- January 1, 2030
- Enrollment
- 2,241 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenomyosis, in vitro fertilization